Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio-ligand binding assay.

A method for the purification, conjugation, and use of EGF-R antibody to quantify EGF receptors on tumour cells by flow cytometry is described. The quantification of both internal and external EGF receptors was determined by treatment with saponin, rendering the cells permeable to the EGF-R antibody. Using QCS bead standards, the number of EGF-R binding sites per cell was assessed. Results were compared with conventional EGF-R quantification using a radio-ligand binding assay. A high degree of correlation was found between the two methods. The flow cytometric method for EGF-R quantification described is simple, rapid, and reproducible. The assay may be of particular value in measuring EGF-R on urgent clinical samples or those that are too small (such as breast aspirates) for measurement by the radio-ligand binding assay. Advantages of this assay over the radio-ligand binding assay include reduction in use of radio-labelled iodine compounds, a decrease in analysis time, and reduced cost and quantity of material needed for assay. In addition, flow cytometry offers the possibility of selecting cell phenotypes by gating as well as live/dead cells by using multi-parameter flow cytometry.

[1]  R. Beuerman,et al.  EGF cell surface receptor quantitation on ocular cells by an immunocytochemical flow cytometry technique. , 1992, Investigative Ophthalmology and Visual Science.

[2]  A. Givan,et al.  The effect of improvements in cytometer sensitivity on the detection of CD5-positive B cells with dim fluorescence. , 1991, Cytometry.

[3]  R. Holman,et al.  Enumeration of antigen sites on cells by flow cytometry. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[4]  A. Givan,et al.  A flow cytometric technique for simultaneous analysis of human mononuclear cell surface antigens and DNA. , 1989, Journal of immunological methods.

[5]  A. Harris,et al.  Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut‐off points of clinical relevance , 1988, International journal of cancer.

[6]  J. Farndon,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.

[7]  D. Fabbro,et al.  Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. , 1986, Cancer research.

[8]  D. Appleton,et al.  Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. , 1985, Journal of clinical pathology.

[9]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.

[10]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER , 1985 .

[11]  G. Schultz,et al.  Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. , 1984, Cancer research.

[12]  Y. Imai,et al.  Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. , 1982, Cancer research.

[13]  B. Hamilton,et al.  Receptor binding and processing of epidermal growth factor by human breast cancer cells. , 1982, The Journal of clinical endocrinology and metabolism.

[14]  J. Hall,et al.  The use of detergents and immunoperoxidase reagents for the ultrastructural demonstration of internal immunoglobulin in lymph cells. , 1978, Journal of immunological methods.